Zortix
Sign in
HIMSBULLLLYNOVO-B.COMIXEDCore thesis · 5/5

GLP-1 ecosystem expansion drives growth for Hims

Hims & Hers is positioned to capture massive demand for GLP-1 weight-loss medications through direct partnerships with major pharma manufacturers, low-cost options, and personalized dosing capabilities.

Sign in to read the full idea

The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.

NOT INVESTMENT ADVICE · A SUMMARY OF WHAT WAS SAID ON THE PODCAST · VERIFY AGAINST THE SOURCE